These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 19491186)

  • 21. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.
    Araki K; Hara M; Tsugawa T; Shimanoe C; Nishida Y; Matsuo M; Tanaka K
    Vaccine; 2018 Aug; 36(34):5187-5193. PubMed ID: 30037664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
    Bégué RE; Perrin K
    Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotavirus prevalence in the primary care setting in Nicaragua after universal infant rotavirus immunization.
    Becker-Dreps S; Paniagua M; Zambrana LE; Bucardo F; Hudgens MG; Weber DJ; Morgan DR; Espinoza F
    Am J Trop Med Hyg; 2011 Nov; 85(5):957-60. PubMed ID: 22049057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Tate J; Leshem E; Mercado J; Umaña J; Balmaceda A; Reyes M; Kerin T; McDonald S; Gentsch J; Bowen MD; Parashar U
    Clin Infect Dis; 2016 May; 62 Suppl 2():S127-32. PubMed ID: 27059346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016.
    Payne DC; Englund JA; Weinberg GA; Halasa NB; Boom JA; Staat MA; Selvarangan R; Azimi PH; Klein EJ; Szilagyi PG; Chappell J; Sahni LC; McNeal M; Harrison CJ; Moffatt ME; Johnston SH; Mijatovic-Rustempasic S; Esona MD; Tate JE; Curns AT; Wikswo ME; Sulemana I; Bowen MD; Parashar UD
    JAMA Netw Open; 2019 Sep; 2(9):e1912242. PubMed ID: 31560386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
    Joensuu J; Koskenniemi E; Pang XL; Vesikari T
    Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).
    Dennehy PH; Vesikari T; Matson DO; Itzler RF; Dallas MJ; Goveia MG; DiNubile MJ; Heaton PM; Ciarlet M
    Hum Vaccin; 2011 May; 7(5):563-8. PubMed ID: 21441783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
    De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
    Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of the monovalent rotavirus vaccine in Colombia: a case-control study.
    Cotes-Cantillo K; Paternina-Caicedo A; Coronell-Rodríguez W; Alvis-Guzmán N; Parashar UD; Patel M; De la Hoz-Restrepo F
    Vaccine; 2014 May; 32(25):3035-40. PubMed ID: 24699470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
    Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
    Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia.
    Beres LK; Tate JE; Njobvu L; Chibwe B; Rudd C; Guffey MB; Stringer JS; Parashar UD; Chilengi R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S175-82. PubMed ID: 27059353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.
    Payne DC; Boom JA; Staat MA; Edwards KM; Szilagyi PG; Klein EJ; Selvarangan R; Azimi PH; Harrison C; Moffatt M; Johnston SH; Sahni LC; Baker CJ; Rench MA; Donauer S; McNeal M; Chappell J; Weinberg GA; Tasslimi A; Tate JE; Wikswo M; Curns AT; Sulemana I; Mijatovic-Rustempasic S; Esona MD; Bowen MD; Gentsch JR; Parashar UD
    Clin Infect Dis; 2013 Jul; 57(1):13-20. PubMed ID: 23487388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean.
    Velázquez RF; Linhares AC; Muñoz S; Seron P; Lorca P; DeAntonio R; Ortega-Barria E
    BMC Pediatr; 2017 Jan; 17(1):14. PubMed ID: 28086819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotavirus vaccine effectiveness in Latin American and Caribbean countries: A systematic review and meta-analysis.
    de Oliveira LH; Camacho LA; Coutinho ES; Ruiz-Matus C; Leite JP
    Vaccine; 2015 May; 33 Suppl 1():A248-54. PubMed ID: 25919169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study.
    Ichihara MY; Rodrigues LC; Teles Santos CA; Teixeira Mda G; De Jesus SR; Alvim De Matos SM; Gagliardi Leite JP; Barreto ML
    Vaccine; 2014 May; 32(23):2740-7. PubMed ID: 24508336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
    Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
    Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost effectiveness evaluation of a rotavirus vaccination program in Argentina.
    Martí SG; Alcaraz A; Valanzasca P; McMullen M; Standaert B; Garay U; Lepetic A; Gomez J
    Vaccine; 2015 Oct; 33(42):5684-5690. PubMed ID: 26303875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of rotavirus vaccines against hospitalisations in Japan.
    Fujii Y; Noguchi A; Miura S; Ishii H; Nakagomi T; Nakagomi O; Takahashi T
    BMC Pediatr; 2017 Jul; 17(1):156. PubMed ID: 28693503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.
    Tate JE; Ngabo F; Donnen P; Gatera M; Uwimana J; Rugambwa C; Mwenda JM; Parashar UD
    Clin Infect Dis; 2016 May; 62 Suppl 2():S208-12. PubMed ID: 27059358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.